variational.ai
What is variational.ai?
Variational AI, .
Variational AI offers Enki™, a platform that provides a foundation model for small molecule discovery, focusing on generating novel drug-like molecules with optimized properties for defined targets. With early access available for 100 kinase targets and the capability to add new targets regularly, Enki™ simplifies the process of creating novel molecule structures in just four easy steps.
By leveraging generative algorithms trained on extensive experimental data, Enki™ allows users to define target product profiles and properties within minutes, covering over 90 kinases such as AXL, EGFR, and PIK3. Founded by a team of experienced AI and machine learning researchers in 2019, Variational AI aims to revolutionize drug discovery and development through cutting-edge generative AI technologies in close collaboration with biopharmaceutical partners across diverse disease areas.
KEY FEATURES
- ✔️ Generative algorithms.
- ✔️ Small molecule discovery.
- ✔️ Target product profiles.
- ✔️ Easy molecule structure creation.
- ✔️ Collaboration with biopharmaceutical partners.
USE CASES
- Accelerate the drug discovery process by utilizing Enki™ to generate novel drug-like molecules tailored to specific kinase targets, reducing time and resources required for manual molecule design and optimization.
- Enhance collaboration within research teams by leveraging Enki™ to quickly define target product profiles and properties, allowing researchers to work together in real-time to develop optimized molecules for a variety of kinase targets.
- Streamline the molecule design process by using Enki™ to automatically generate diverse molecular structures with optimized properties, empowering researchers to focus on analyzing and validating potential drug candidates rather than spending time on manual molecule generation.